These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1913229)
1. Fatal thrombocytopenia and liver failure associated with carboplatin therapy. Hruban RH; Sternberg SS; Meyers P; Fleisher M; Menendez-Botet C; Boitnott JK Cancer Invest; 1991; 9(3):263-8. PubMed ID: 1913229 [TBL] [Abstract][Full Text] [Related]
2. A phase I study of carboplatin in children with acute leukemia in bone marrow relapse. A report from the Childrens Cancer Group. Ettinger LJ; Krailo MD; Gaynon PS; Hammond GD Cancer; 1993 Aug; 72(3):917-22. PubMed ID: 8334645 [TBL] [Abstract][Full Text] [Related]
3. Phase II clinical trial of carboplatin in relapsed and refractory leukemia. Vogler WR; Harrington DP; Winton EF; Lazarus HM; Bennett JM; Cassileth PA; Oken MM Leukemia; 1992 Oct; 6(10):1072-5. PubMed ID: 1405761 [TBL] [Abstract][Full Text] [Related]
4. Phase I-II trial of concomitant continuous carboplatin (CBDCA) infusion and radiotherapy in advanced nonsmall cell lung cancer with evaluation for surgery: final report. Trodella L; Cellini N; Picciocchi A; Marano P; Balducci M; Mantini G; Turriziani A; Corbo GM; Valente S; Valentini V; Pirronti T; Granone P; Dobelbower RR Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):93-101. PubMed ID: 9054882 [TBL] [Abstract][Full Text] [Related]
5. A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children's Cancer Group. Ettinger LJ; Ivy P; Gaynon PS; Ettinger AG; Liu-Mares W; Krailo MD Cancer; 1997 Jul; 80(2):311-6. PubMed ID: 9217045 [TBL] [Abstract][Full Text] [Related]
6. Prediction of hematologic toxicity of carboplatin by creatinine clearance rate. Taguchi J; Saijo N; Miura K; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Sakurai M; Minato K; Fujiwara Y Jpn J Cancer Res; 1987 Sep; 78(9):977-82. PubMed ID: 3117753 [TBL] [Abstract][Full Text] [Related]
7. High-dose carboplatin in the treatment of hematologic malignancies. Vogler WR Oncology; 1993 Nov; 50 Suppl 2():42-6. PubMed ID: 8233301 [TBL] [Abstract][Full Text] [Related]
8. A phase I trial of carboplatin and etoposide given as continuous infusions to adults with leukemia. Lee EJ; Reck K; Carter C; Hodges S; Schiffer CA Leukemia; 1993 Oct; 7(10):1500-3. PubMed ID: 8412310 [TBL] [Abstract][Full Text] [Related]
9. Infusion carboplatin treatment of relapsed and refractory acute leukemia: evidence of efficacy with minimal extramedullary toxicity at intermediate doses. Meyers FJ; Welborn J; Lewis JP; Flynn N J Clin Oncol; 1989 Feb; 7(2):173-8. PubMed ID: 2644396 [TBL] [Abstract][Full Text] [Related]
10. A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia. Cooper BW; Veal GJ; Radivoyevitch T; Tilby MJ; Meyerson HJ; Lazarus HM; Koc ON; Creger RJ; Pearson G; Nowell GM; Gosky D; Ingalls ST; Hoppel CL; Gerson SL Clin Cancer Res; 2004 Oct; 10(20):6830-9. PubMed ID: 15501959 [TBL] [Abstract][Full Text] [Related]
15. Continuous infusion etoposide/carboplatin for treatment of refractory acute leukemia. Letendre L; Noel P; Tefferi A; Solberg LA; Gastineau DA; Hoagland HC Am J Clin Oncol; 1995 Oct; 18(5):382-4. PubMed ID: 7572751 [TBL] [Abstract][Full Text] [Related]
16. Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy. Shea TC; Mason JR; Storniolo AM; Newton B; Breslin M; Mullen M; Ward DM; Miller L; Christian M; Taetle R J Clin Oncol; 1992 Mar; 10(3):464-73. PubMed ID: 1740685 [TBL] [Abstract][Full Text] [Related]
17. Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma. A study of the Lung Cancer Study Group of West Japan. Katakami N; Takada M; Negoro S; Ota K; Fujita J; Furuse K; Ariyoshi Y; Ikegami H; Fukuoka M Cancer; 1996 Jan; 77(1):63-70. PubMed ID: 8630941 [TBL] [Abstract][Full Text] [Related]
18. Dose escalation study of carboplatin and cyclophosphamide with filgrastim support: a phase I study. Toner GC; Green M; Bishop JF; McKendrick J; Cebon J; Sheridan WP; Lockbaum P; O'Byrne J; Fox RM Am J Clin Oncol; 1998 Jun; 21(3):263-9. PubMed ID: 9626795 [TBL] [Abstract][Full Text] [Related]
19. Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole. Yang CH; Yang LJ; Jaing TH; Chan HL Int J Dermatol; 2000 Aug; 39(8):621-3. PubMed ID: 10971734 [TBL] [Abstract][Full Text] [Related]
20. Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results. Li S; Huang H; Liao H; Zhan J; Guo Y; Zou BY; Jiang WQ; Guan ZZ; Yang XQ Int J Clin Pharmacol Ther; 2013 Feb; 51(2):96-105. PubMed ID: 23127487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]